Adaptive Biotechnologies (ADPT) Insider Trading & Ownership $7.38 +0.37 (+5.28%) Closing price 04/23/2025 04:00 PM EasternExtended Trading$7.36 -0.02 (-0.34%) As of 04/23/2025 05:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Adaptive Biotechnologies (NASDAQ:ADPT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.20%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$6.04 M Get ADPT Insider Trade Alerts Want to know when executives and insiders are buying or selling Adaptive Biotechnologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ADPT Insider Buying and Selling by Quarter Adaptive Biotechnologies Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/24/2025Harlan S RobinsInsiderSell1,698$9.00$15,282.00 3/12/2025Robert HershbergDirectorSell53,000$7.59$402,270.00 3/10/2025Peter M NeupertDirectorSell10,000$7.05$70,500.00 3/6/2025Michelle Renee GriffinDirectorSell15,664$7.94$124,372.16 3/5/2025Chad M RobinsCEOSell117,351$6.98$819,109.98 3/5/2025Francis LoInsiderSell20,875$6.99$145,916.25 3/5/2025Julie RubinsteinCOOSell59,505$6.98$415,344.90 3/5/2025Kyle PiskelCFOSell10,320$6.98$72,033.60 2/20/2025Chad M RobinsCEOSell99,107$8.44$836,463.08 2/18/2025Chad M RobinsCEOSell211,160$8.50$1,794,860.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/14/2025Chad M RobinsCEOSell158,921$8.46$1,344,471.66 11/18/2024Kyle PiskelCFOSell248$4.98$1,235.04 (Data available from 1/1/2013 forward) ADPT Insider Trading Activity - Frequently Asked Questions Who is on Adaptive Biotechnologies's Insider Roster? The list of insiders at Adaptive Biotechnologies includes Chad M Robins, Francis Lo, Harlan S Robins, Julie Rubinstein, Kyle Piskel, Michelle Renee Griffin, Nitin Sood, Peter M Neupert, R Mark Adams, Robert Hershberg, Stacy L Taylor, and Tycho Peterson. Learn more on insiders at ADPT. What percentage of Adaptive Biotechnologies stock is owned by insiders? 6.20% of Adaptive Biotechnologies stock is owned by insiders. Learn more on ADPT's insider holdings. Which Adaptive Biotechnologies insiders have been selling company stock? The following insiders have sold ADPT shares in the last 24 months: Chad M Robins ($4,961,853.11), Francis Lo ($145,916.25), Harlan S Robins ($15,282.00), Julie Rubinstein ($550,917.80), Kyle Piskel ($100,841.92), Michelle Renee Griffin ($124,372.16), Nitin Sood ($38,320.56), Peter M Neupert ($70,500.00), Robert Hershberg ($402,270.00), Stacy L Taylor ($45,896.83), and Tycho Peterson ($2,020,931.18). How much insider selling is happening at Adaptive Biotechnologies? Insiders have sold a total of 1,131,028 Adaptive Biotechnologies shares in the last 24 months for a total of $8,477,101.81 sold. Adaptive Biotechnologies Key ExecutivesMr. Chad M. Robins M.B.A. (Age 49)Co-Founder, CEO & Chairman Compensation: $1M4 recent tradesMs. Julie Rubinstein (Age 52)President & COO Compensation: $721.04k1 recent tradesDr. Harlan S. Robins Ph.D. (Age 51)Co-Founder & Chief Scientific Officer Compensation: $711.09kDr. Sharon Benzeno Ph.D. (Age 50)Chief Commercial Officer of Immune Medicine Compensation: $630.72kMr. Christopher Carlson Ph.D.FounderMr. Kyle Piskel (Age 40)VP, CFO & Principal Accounting Officer Compensation: $375.9k2 recent tradesKarina CalzadillaVice President of Investor RelationsMs. Stacy L. Taylor (Age 64)Senior VP, General Counsel & Corporate Secretary Mr. Francis T. Lo (Age 43)Chief People Officer 1 recent tradesMs. Susan Bobulsky (Age 43)Chief Commercial Officer of MRD More Insider Trading Tools from MarketBeat Related Companies Vaxcyte Insider Trading Rhythm Pharmaceuticals Insider Trading PTC Therapeutics Insider Trading Avidity Biosciences Insider Trading Arcellx Insider Trading Ultragenyx Pharmaceutical Insider Trading Zai Lab Insider Trading Akero Therapeutics Insider Trading Merus Insider Trading Scholar Rock Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market Sentiment This page (NASDAQ:ADPT) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptive Biotechnologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adaptive Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
